1 – 10 of 29
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Caveolin-1 gene expression provides additional prognostic information combined with PAM50 risk of recurrence (ROR) score in breast cancer
(
- Contribution to journal › Article
-
Mark
Potential interplay between tumor size and vitamin D receptor (VDR) polymorphisms in breast cancer prognosis : a prospective cohort study
2024) In Cancer Causes and Control(
- Contribution to journal › Article
- 2022
-
Mark
Statin use and patterns of breast cancer recurrence in the Malmö Diet and Cancer Study
(
- Contribution to journal › Article
- 2021
-
Mark
Pre- and Postoperative Circulating IGF-I, IGFBP-3, and IGFBP-7 Levels in Relation to Endocrine Treatment and Breast Cancer Recurrence : A Nested Case-Control Study
(
- Contribution to journal › Article
-
Mark
The Prognostic Impact of Intratumoral Aryl Hydrocarbon Receptor in Primary Breast Cancer Depends on the Type of Endocrine Therapy : A Population-Based Cohort Study
(
- Contribution to journal › Article
- 2020
-
Mark
Prognostic Impact of Menopausal Hormone Therapy in Breast Cancer Differs According to Tumor Characteristics and Treatment
(
- Contribution to journal › Article
-
Mark
Patient Characteristics Influence Activated Signal Transducer and Activator of Transcription 3 (STAT3) Levels in Primary Breast Cancer—Impact on Prognosis
(
- Contribution to journal › Article
-
Mark
CYP27A1 expression is associated with risk of late lethal estrogen receptor-positive breast cancer in postmenopausal patients
(
- Contribution to journal › Article
- 2019
-
Mark
The impact of body size changes on recurrence risk depends on age and estrogen receptor status in primary breast cancer
(
- Contribution to journal › Article
- 2018
-
Mark
Interactions between ABCB1genotype and preoperative statin use impact clinical outcomes among breast cancer patients
(
- Contribution to journal › Article